Product Comparison


 

No Image

Dr. Reddy's Laboratories 55111068852
Dr. Reddy's Laboratories 55111068507

No Image

No Image

McKesson # 1059150 835520 835519 1135235 1160307
Description Single Dose Vial 100 mL Zoledronic Acid 5 mg / 100 mL Ready to Use Intravenous Injection Infusion Bottle 100 mL Zoledronic Acid 4 mg / 5 mL Concentrate Intravenous Injection Single Use Vial 5 mL 1 mg / mL Injection 3 mL 3 mg / mL Injection 1 mL
Manufacturer # 6332309660055111068852551110685076745705243360505609700
Brand      
Manufacturer Fresenius USADr. Reddy's LaboratoriesDr. Reddy's LaboratoriesMylan PharmaceuticalsApotex
Invoice ZOLEDRON ACID, SDV 5MG/100ML 100MLZOLEDRONIC ACID, SDV 5MG 100MLZOLEDRONIC ACID, SDV 0.8MG/ML 5MLIBANDRONATE SOD, SYR 1MG/ML 3MLIBANDRONATE SOD, SYR 3MG/3ML 1MG/ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 2017226201723432437063513678
Application Bone Resorption InhibitorBone Resorption Inhibitor
Container Type Single Dose VialInfusion BottleSingle Use Vial
Dosage Form InjectionInjectionInjectionInjection
Generic Drug Code 2502619476
Generic Drug Name Zoledronic AcidZoledronic Acid
NDC Number 6332309660055111-0688-5255111-0685-076745705243360505609700
Strength 5 mg / 100 mL Ready to Use4 mg / 5 mL Concentrate1 mg / mL3 mg / mL
Type IntravenousIntravenous
UNSPSC Code 5118241551182415511824155118242351182423
Volume 100 mL100 mL5 mL3 mL1 mL
Country of Origin UnknownUnknownUnknownUnknownUnknown
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits
  • Ready-to-use formulation
  • Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
  • The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
  • Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
  • Infusion bottle with built-in plastic hanger
  • One bottle with 100 mL solution contains 5.330 mg of zoledronic acid monohydrate, equivalent to 5 mg zoledronic acid on an anhydrous basis
  • Inactive Ingredients: 4950 mg of mannitol, USP; and 30 mg of sodium citrate, USP
  • Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
  • Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
  • Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
  • Vials of zoledronic acid injection concentrate for infusion contain overfill allowing for the withdrawal of 5 mL of concentrate (equivalent to 4 mg zoledronic acid)
  • This concentrate should immediately be diluted in 100 mL of sterile 0.9% Sodium Chloride, USP, or 5% Dextrose Injection, USP following proper aseptic technique, and administered to the patient by infusion
  • Do not store undiluted concentrate in a syringe, to avoid inadvertent injection
  • If not used immediately after dilution with infusion media, for microbiological integrity, the solution should be refrigerated at 2°C-8°C (36°F-46°F)
  • Due to the risk of clinically significant deterioration in renal function, which may progress to renal failure, single doses of zoledronic acid injection should not exceed 4 mg and the duration of infusion should be no less than 15 minutes